Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences.
Access status:
Open Access
Type
Article, LetterAbstract
The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response rate (83%) among the 326 patients (13% of the total cohort) that had used a cannabis-based medicine. Notwithstanding the small sample size, it still constitutes an evaluable response rate, given that the use of cannabis for medicinal purposes in
Denmark is permitted.The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response rate (83%) among the 326 patients (13% of the total cohort) that had used a cannabis-based medicine. Notwithstanding the small sample size, it still constitutes an evaluable response rate, given that the use of cannabis for medicinal purposes in
Denmark is permitted.
See less
See less
Date
2022Source title
Supportive Care in CancerPublisher
Springer NatureLicence
Copyright All Rights ReservedFaculty/School
Faculty of Medicine and Health, The University of Sydney School of PharmacyShare